Skip to main content
. 2022 Aug 15;12(4):125–135.

Figure 4.

Figure 4

Al-hijamah significantly enhanced immunity in thalassemic patients receiving iron chelation therapy. A. CD4+ T cell count significantly increased when combining iron chelation therapy with Al-hijamah (P<0.01). B. CD8+ T cell count significantly increased when combining iron chelation therapy with Al-hijamah (P<0.05). C. TAC/MDA ratio significantly increased ten times after Al-hijamah. D. CD4/CD8 ratio significantly increased after Al-hijamah. N.B. All studied patients were thalassemic patients receiving iron chelation therapy. Control group did not undergo Al-hijamah treatment. There is no healthy control. * indicated P<0.05 and ** indicated P<0.01 within the same group (intervention group). ## indicated P<0.01 to compare results between different groups (patients versus controls).